Drug use and medication adherence among HIV-1 infected individuals

被引:244
作者
Hinkin, Charles H.
Barclay, Terry R.
Castellon, Steven A.
Levine, Andrew J.
Durvasula, Ramani S.
Marion, Sarah D.
Myers, Hector F.
Longshore, Douglas
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90024 USA
[2] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA
[3] Calif State Univ Los Angeles, Los Angeles, CA 90032 USA
[4] Point Loma Univ, San Diego, CA USA
[5] Charles R Drew Univ Med & Sci, Res Ctr Ethn Hlth & Behav, Los Angeles, CA 90059 USA
关键词
HIV infection; AIDS; medication adherence; drug use; methamphetamine; cocaine;
D O I
10.1007/s10461-006-9152-0
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
This longitudinal study examined the impact of drug use and abuse on medication adherence among 150 HIV-infected individuals, 102 who tested urinalysis positive for recent illicit drug use. Medication adherence was tracked over a 6-month period using an electronic monitoring device (MEMS caps). Over the 6-month study drug-positive participants demonstrated significantly worse medication adherence than did drug-negative participants (63 vs. 79%, respectively). Logistic regression revealed that drug use was associated with over a fourfold greater risk of adherence failure. Stimulant users were at greatest risk for poor adherence. Based upon within-participants analyses comparing 3-day adherence rates when actively using versus not using drugs, this appears to be more a function of state rather than trait. These data suggest that it is the acute effects of intoxication, rather than stable features that may be characteristic of the drug-using populace, which leads to difficulties with medication adherence.
引用
收藏
页码:185 / 194
页数:10
相关论文
共 58 条
[1]   Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users [J].
Arnsten, JH ;
Demas, PA ;
Grant, RW ;
Gourevitch, MN ;
Farzodegan, H ;
Howard, AA ;
Schoenboum, EE .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2002, 17 (05) :377-381
[2]   Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring [J].
Arnsten, JH ;
Demas, PA ;
Farzadegan, H ;
Grant, RW ;
Gourevitch, MN ;
Chang, CJ ;
Buono, D ;
Eckholdt, H ;
Howard, AA ;
Schoenbaum, EE .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (08) :1417-1423
[3]   Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population [J].
Bangsberg, DR ;
Hecht, FM ;
Charlebois, ED ;
Zolopa, AR ;
Holodniy, M ;
Sheiner, L ;
Bamberger, JD ;
Chesney, MA ;
Moss, A .
AIDS, 2000, 14 (04) :357-366
[4]   A computer-based assessment detects regimen misunderstandings and nonadherence for patients on HIV antiretroviral therapy [J].
Bangsberg, DR ;
Bronstone, A ;
Hofman, R .
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2002, 14 (01) :3-15
[5]   Gender differences in factors associated with adherence to antiretroviral therapy [J].
Berg, KM ;
Demas, PA ;
Howard, AA ;
Schoenbaum, EE ;
Gourevitch, MN ;
Arnsten, JH .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2004, 19 (11) :1111-1117
[6]  
BURKE LE, 2001, COMPLIANCE HEALTHCAR
[7]   Adherence to single daily dose of aspirin in a chemoprevention trial - An evaluation of self-report and microelectronic monitoring [J].
Burney, KD ;
Krishnan, K ;
Ruffin, MT ;
Zhang, DW ;
Brenner, DE .
ARCHIVES OF FAMILY MEDICINE, 1996, 5 (05) :297-300
[8]   Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users [J].
Chang, L ;
Ernst, T ;
Speck, O ;
Patel, H ;
DeSilva, M ;
Leonido-Yee, M ;
Miller, EN .
PSYCHIATRY RESEARCH-NEUROIMAGING, 2002, 114 (02) :65-79
[9]   Comparison of patient self-reports and urinalysis results obtained under naturalistic methadone treatment conditions [J].
Chermack, ST ;
Roll, J ;
Reilly, M ;
Davis, L ;
Kilaru, U ;
Grabowski, J .
DRUG AND ALCOHOL DEPENDENCE, 2000, 59 (01) :43-49
[10]   Adherence to HIV combination therapy [J].
Chesney, MA ;
Morin, M ;
Sherr, L .
SOCIAL SCIENCE & MEDICINE, 2000, 50 (11) :1599-1605